Revels Sha'Shonda L, Wong Sandra L, Banerjee Mousumi, Yin Huiying, Birkmeyer John D
Department of Surgery and Center for Healthcare Outcomes & Policy, University of Michigan, Ann Arbor, MI, USA.
Ann Surg Oncol. 2014 Jul;21(7):2129-35. doi: 10.1245/s10434-014-3692-8. Epub 2014 Apr 8.
To evaluate adherence to perioperative processes of care associated with major cancer resections.
Mortality rates associated with major cancer resections vary across hospitals. Because mechanisms underlying such variations are not well-established, we studied adherence to perioperative care processes.
There were 1,279 hospitals participating in the National Cancer DataBase (2005-2006) ranked on a composite measure of mortality for bladder, colon, esophagus, stomach, lung, and pancreas cancer operations. We sampled hospitals from among those with the lowest and highest mortality rates, with 19 low-mortality hospitals [(LMHs), risk-adjusted mortality rate of 2.84 %] and 30 high-mortality hospitals [(HMHs), risk-adjusted mortality rate of 7.37 %]. We then conducted onsite chart reviews. Using logistic regression, we examined differences in perioperative care, adjusting for patient and tumor characteristics.
Compared to LMHs, HMHs were less likely to use prophylaxis against venous thromboembolism, either preoperative or postoperatively [adjusted relative risk (aRR) 0.74, 95 % CI 0.50-0.92 and aRR 0.80, 95 % CI 0.56-0.93, respectively]. The two hospital groups were indistinguishable with respect to processes aimed at preventing surgical site infections, such as the use of antibiotics prior to incision (aRR, 0.99, 95 % CI 0.90-1.04), and processes intended to prevent cardiac events, including the use of β-blockers (1.00, 95 % CI 0.81-1.14). HMHs were significantly less likely to use epidurals (aRR, 0.57, 95 % CI 0.32-0.93).
HMHs and LMHs differ in several aspects of perioperative care. These areas may represent opportunities for improving cancer surgery quality at hospitals with high mortality.
评估与重大癌症切除术相关的围手术期护理流程的依从性。
重大癌症切除术的死亡率在不同医院有所差异。由于此类差异背后的机制尚未明确确立,我们对围手术期护理流程的依从性进行了研究。
有1279家医院参与了国家癌症数据库(2005 - 2006年),这些医院根据膀胱癌、结肠癌、食管癌、胃癌、肺癌和胰腺癌手术的综合死亡率指标进行排名。我们从死亡率最低和最高的医院中进行抽样,其中19家低死亡率医院(LMHs,风险调整死亡率为2.84%)和30家高死亡率医院(HMHs,风险调整死亡率为7.37%)。然后我们进行了现场病历审查。使用逻辑回归分析,我们在调整患者和肿瘤特征后,研究了围手术期护理的差异。
与低死亡率医院相比,高死亡率医院术前或术后使用静脉血栓栓塞预防措施的可能性较小[调整后相对风险(aRR)分别为0.74,95%置信区间0.50 - 0.92和aRR 0.80,95%置信区间0.56 - 0.93]。在旨在预防手术部位感染的流程方面,如切口前使用抗生素(aRR,0.99,95%置信区间0.90 - 1.04),以及旨在预防心脏事件的流程方面,包括使用β受体阻滞剂(1.00,95%置信区间0.81 - 1.14),这两组医院没有差异。高死亡率医院使用硬膜外麻醉的可能性显著较小(aRR,0.57,95%置信区间0.32 - 0.93)。
高死亡率医院和低死亡率医院在围手术期护理的几个方面存在差异。这些领域可能代表了高死亡率医院提高癌症手术质量的机会。